91133-71-0 Usage
Uses
Used in Pharmaceutical Industry:
4-ACETAMIDO-2-METHYLBENZOIC ACID METHYL ESTER serves as a crucial intermediate in the synthesis of various pharmaceutical drugs. It is used as a building block for the development of anti-inflammatory and analgesic medications, contributing to the treatment of pain and inflammation.
Used in Organic Synthesis:
Beyond its pharmaceutical applications, 4-ACETAMIDO-2-METHYLBENZOIC ACID METHYL ESTER is also utilized in the synthesis of a range of organic compounds. Its versatility in chemical reactions makes it a valuable component in the creation of diverse chemical products.
Used in Cosmetic and Personal Care Products:
4-ACETAMIDO-2-METHYLBENZOIC ACID METHYL ESTER can be found in some cosmetic and personal care products, where it may contribute to the formulation of creams, lotions, and other skincare items, potentially leveraging its anti-inflammatory properties for topical applications.
It is important to handle 4-ACETAMIDO-2-METHYLBENZOIC ACID METHYL ESTER with care due to its potential to cause irritation to the skin, eyes, and respiratory system. Proper safety measures should be taken during its use in laboratories and manufacturing processes.
Check Digit Verification of cas no
The CAS Registry Mumber 91133-71-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,1,1,3 and 3 respectively; the second part has 2 digits, 7 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 91133-71:
(7*9)+(6*1)+(5*1)+(4*3)+(3*3)+(2*7)+(1*1)=110
110 % 10 = 0
So 91133-71-0 is a valid CAS Registry Number.
91133-71-0Relevant academic research and scientific papers
FUSED PYRIMIDINE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF FIBROTIC DISEASES
-
, (2021/02/25)
The present invention discloses compounds according to Formula I: Wherein A, B, R1, R2, and Cy are as defined herein. The present invention relates to compounds inhibiting autotaxin (NPP2 or ENPP2), methods for their production, pharmaceutical compositions comprising the same, and methods of treatment using the same, for the prophylaxis and/or treatment of fibrotic diseases, proliferative diseases, inflammatory diseases, autoimmune diseases, respiratory diseases, cardiovascular diseases, neurodegenerative diseases, dermatological disorders, pain, and/or abnormal angiogenesis associated diseases by administering the compounds of the invention.
